Back to Search Start Over

Gene Therapy with a Self-inactivating (SIN) Gammaretrovirus Vector in 9 patients with X-Linked Severe Combined Immunodeficiency (SCID-X1) Results in Similar Efficacy and an Altered Vector Insertion Profile Compared to Previous Trials

Tools

Authors Abstract Subjects Details